EPIRUS Biopharma to Slash 40% of Workforce, Suspend Lead Clinical Program and Replaces CEO
Pulitzer Prize Author of “Emperor of All Maladies” Launches Biotech Startup Vor BioPharma in Boston
Medivation (MDVN) Takeover Saga Takes Another Turn, Rumored to Open Books to Amgen (AMGN) and Pfizer (PFE)
Hours After Debuting Biotech Startup Vor BioPharma, PureTech Launches Alivio Therapeutics
BioDelivery (BDSI) Consolidating the Sales Force Size in Cost-Cutting Move
San Diego's Sorrento (SRNE) Hires Advisors to Mull Over Strategic Options
RXi Pharma (RXII) to Explore Strategic Options, Including Possible M&A
Naurex Spinout Aptinyx Banks $65 Million Series A to Advance Therapies for Neurological Disorders
Biogen (BIIB)'s Partner AC Immune SA Reels In $43.5 Million for Alzheimer's and Neurodegenerative Diseases R&D
NewLink Genetics (NLNK) Craters as Pancreatic Cancer Vaccine Fails Phase III Study, May Even Harm Patients
Medicure (MCU) COO Terminated, Effective Immediately
Bay Area's Alexza Pharma (ALXA) Sold in $35 Million Deal
Taiho Pharma Forms Venture Arm in California to Foster Cancer Biotech Start-ups
Documents Reveal Valeant (VRX) Offered Philidor Up to $100 Million in Bonuses for Hitting Marks, Ackman's Appeal to Buffett
Arena (ARNA) Names EPIRUS Biopharma's Amit D. Munshi as New CEO
Gilead (GILD) CEO Targets Cancer Acquisitions with $21 Billion Cash Pile
AstraZeneca PLC (AZN) Employees from Shuttered Facility Could be Relocated to Delaware
Facebook's Oculus Rift Developer Resigns to Work on Wearable MRI Startup
See All News >
//-->